Personalized Antiplatelet Secondary Stroke PRevenTion

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

May 9, 2023

Study Completion Date

May 9, 2023

Conditions
Ischemic StrokeTIA
Interventions
DRUG

tailored antiplatelet selection

antiplatelet selection guided by platelet function phenotype and/or key pharmacogene genotypes

DRUG

standard of care

antiplatelet selection using standard of care

Trial Locations (1)

13202

SUNY Upstate Medical University, Syracuse

All Listed Sponsors
lead

State University of New York - Upstate Medical University

OTHER

NCT03979781 - Personalized Antiplatelet Secondary Stroke PRevenTion | Biotech Hunter | Biotech Hunter